"Bone Marrow" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.
| Descriptor ID |
D001853
|
| MeSH Number(s) |
A15.382.216
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bone Marrow".
Below are MeSH descriptors whose meaning is more specific than "Bone Marrow".
This graph shows the total number of publications written about "Bone Marrow" by people in this website by year, and whether "Bone Marrow" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 6 | 12 |
| 1995 | 1 | 8 | 9 |
| 1996 | 7 | 5 | 12 |
| 1997 | 1 | 7 | 8 |
| 1998 | 2 | 5 | 7 |
| 1999 | 0 | 2 | 2 |
| 2000 | 2 | 4 | 6 |
| 2001 | 2 | 6 | 8 |
| 2002 | 3 | 6 | 9 |
| 2003 | 2 | 3 | 5 |
| 2004 | 0 | 2 | 2 |
| 2005 | 2 | 4 | 6 |
| 2006 | 4 | 2 | 6 |
| 2007 | 1 | 2 | 3 |
| 2008 | 4 | 5 | 9 |
| 2009 | 3 | 3 | 6 |
| 2010 | 3 | 1 | 4 |
| 2011 | 4 | 1 | 5 |
| 2012 | 3 | 1 | 4 |
| 2013 | 6 | 5 | 11 |
| 2014 | 4 | 5 | 9 |
| 2015 | 4 | 4 | 8 |
| 2016 | 2 | 5 | 7 |
| 2017 | 2 | 3 | 5 |
| 2018 | 2 | 4 | 6 |
| 2019 | 3 | 3 | 6 |
| 2020 | 4 | 6 | 10 |
| 2021 | 0 | 6 | 6 |
| 2022 | 1 | 6 | 7 |
| 2023 | 3 | 9 | 12 |
| 2024 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Marrow" by people in Profiles.
-
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study. Am J Clin Pathol. 2024 Sep 03; 162(3):233-242.
-
BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses. Immunity. 2024 Sep 10; 57(9):2095-2107.e8.
-
High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT). Eur J Haematol. 2024 Jul; 113(1):110-116.
-
Measurable Residual Disease and Decision-Making in Multiple Myeloma. Hematol Oncol Clin North Am. 2024 04; 38(2):477-495.
-
Protocol for examining the capability of senescent tumor cells to stimulate murine bone-marrow-derived dendritic cells by flow cytometry. STAR Protoc. 2023 Dec 15; 4(4):102677.
-
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow. Mod Pathol. 2024 Jan; 37(1):100352.
-
Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach. Am J Clin Pathol. 2023 10 03; 160(4):365-393.
-
Mycobacterium tuberculosis infection drives differential responses in the bone marrow hematopoietic stem and progenitor cells. Infect Immun. 2023 10 17; 91(10):e0020123.
-
Germ line risk variants: beyond cancer. Blood. 2023 08 17; 142(7):616-617.
-
Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group. Leuk Res. 2023 07; 130:107309.